Proteoglycans in health and disease: the multiple roles of syndecan shedding
暂无分享,去创建一个
[1] P. Stahl,et al. Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5* , 2008, Journal of Biological Chemistry.
[2] Michael Elkin,et al. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. , 2006, The international journal of biochemistry & cell biology.
[3] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[4] A. Rapraeger,et al. Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. , 2006, Journal of cell science.
[5] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[6] A. Purushothaman,et al. Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma* , 2008, Journal of Biological Chemistry.
[7] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[8] D. Carey,et al. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[9] T. Yoshizaki,et al. Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.
[10] Gillian Murphy,et al. Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.
[11] M. Jalkanen,et al. Cell surface proteoglycan of mouse mammary epithelial cells is shed by cleavage of its matrix-binding ectodomain from its membrane-associated domain , 1987, The Journal of cell biology.
[12] J. Woessner,et al. Heparin-enhanced zymographic detection of matrilysin and collagenases. , 2001, Analytical biochemistry.
[13] S. Uhlig,et al. A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and -4 by Lung Epithelial Cells* , 2009, The Journal of Biological Chemistry.
[14] William C. Parks,et al. Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.
[15] R. Iozzo,et al. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.
[16] Heikki Joensuu,et al. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. , 2002, Cancer research.
[17] J. Fox,et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. , 2000, Biochemical and biophysical research communications.
[18] M. Remberger,et al. Increased levels of syndecan-1 in serum during acute graft-versus-host disease. , 2003, Transplantation.
[19] R. Sanderson,et al. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis , 2010, The FEBS journal.
[20] S. Nadler,et al. MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation , 2009, PloS one.
[21] J. Woodliff,et al. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells , 2000, British journal of haematology.
[22] F. van Roy,et al. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. , 1996, Journal of cell science.
[23] Viktoriya D. Nikolova,et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. , 2009, Carcinogenesis.
[24] L. Suva,et al. Heparanase promotes the spontaneous metastasis of myeloma cells to bone. , 2004, Blood.
[25] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[26] B. de Strooper,et al. Syndecan 3 Intramembrane Proteolysis Is Presenilin/γ-Secretase-dependent and Modulates Cytosolic Signaling* , 2003, Journal of Biological Chemistry.
[27] S. Lee,et al. Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization. , 2000, Journal of cell science.
[28] J. Epstein,et al. Soluble syndecan-1 promotes growth of myeloma tumors in vivo. , 2002, Blood.
[29] J. Spring,et al. Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] M. Angelopoulou,et al. Serum levels of soluble syndecan-1 in Hodgkin's lymphoma. , 2005, Anticancer research.
[31] A. Rapraeger,et al. Syndecan-1 regulates αvβ5 integrin activity in B82L fibroblasts , 2006, Journal of Cell Science.
[32] A. Purushothaman,et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. , 2010, Blood.
[33] Hao Wang,et al. Syndecans, Heparan Sulfate Proteoglycans, Maintain the Proteolytic Balance of Acute Wound Fluids* , 1998, The Journal of Biological Chemistry.
[34] J. Couchman,et al. Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. , 2007, Experimental cell research.
[35] H. Nagase. Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.
[36] H. van den Berghe,et al. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican , 1996, The Journal of cell biology.
[37] J. Couchman,et al. Syndecan proteoglycan contributions to cytoskeletal organization and contractility , 2009, Scandinavian journal of medicine & science in sports.
[38] Masato Kato,et al. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 , 1998, Nature Medicine.
[39] R. Wynn,et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. , 1999, Science.
[40] D. Edwards,et al. The ADAMTS metalloproteinases. , 2005, The Biochemical journal.
[41] J. Heino,et al. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen. , 2008, Experimental cell research.
[42] M. Hengartner,et al. Syndecan regulates cell migration and axon guidance in C. elegans , 2005, Development.
[43] Yeong-Wook Song,et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis , 2009, Nature Medicine.
[44] J. Sandy,et al. ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1* , 2004, Journal of Biological Chemistry.
[45] A. Waage,et al. Serum syndecan-1: a new independent prognostic marker in multiple myeloma. , 2000, Blood.
[46] M. Drayson,et al. Soluble syndecan‐1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival , 2005, British journal of haematology.
[47] A. Rapraeger,et al. The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells , 2004, The Journal of cell biology.
[48] Israel Vlodavsky,et al. Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans , 2008, PloS one.
[49] A. Theocharis,et al. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting , 2010, The FEBS journal.
[50] H. Kitagawa,et al. Heparan sulphate biosynthesis and disease. , 2008, Journal of biochemistry.
[51] M. Götte,et al. Inhibition by the Soluble Syndecan-1 Ectodomains Delays Wound Repair in Mice Overexpressing Syndecan-1* , 2004, Journal of Biological Chemistry.
[52] M. Iruela-Arispe,et al. Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion. , 2009, The international journal of biochemistry & cell biology.
[53] Sheikh Abdul Rahman,et al. Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection , 2009, Journal of Virology.
[54] M. Bernfield,et al. Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation* , 1997, The Journal of Biological Chemistry.
[55] S. Miyakis,et al. Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease , 2005, Clinical chemistry and laboratory medicine.
[56] G. Gibson,et al. Molecular Interactions of MMP-13 C-Terminal Domain with Chondrocyte Proteins , 2010, Connective tissue research.
[57] M. Salmivirta,et al. Selective Effects of Sodium Chlorate Treatment on the Sulfation of Heparan Sulfate* , 1999, The Journal of Biological Chemistry.
[58] Guoying Yu,et al. Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis* , 2009, Journal of Biological Chemistry.
[59] K. MacKenzie,et al. Transmembrane domains of the syndecan family of growth factor coreceptors display a hierarchy of homotypic and heterotypic interactions , 2007, Proceedings of the National Academy of Sciences.
[60] N. Ito,et al. The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface* , 2008, Journal of Biological Chemistry.
[61] G. Pier,et al. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence , 2001, Nature.
[62] G. Murphy,et al. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. , 2008, The Biochemical journal.
[63] R. Gallo,et al. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. , 1996, The Journal of investigative dermatology.
[64] Choll W. Kim,et al. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. , 1994, Molecular biology of the cell.
[65] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[66] S. Cho,et al. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma. , 2003, European urology.
[67] A. Schmidt,et al. Plasmin- and Thrombin-accelerated Shedding of Syndecan-4 Ectodomain Generates Cleavage Sites at Lys114–Arg115 and Lys129–Val130 Bonds* , 2005, Journal of Biological Chemistry.
[68] J. Couchman. Faculty Opinions recommendation of Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. , 2009 .
[69] H. Nakanishi,et al. A Novel Function of Syndecan-2, Suppression of Matrix Metalloproteinase-2 Activation, Which Causes Suppression of Metastasis* , 2007, Journal of Biological Chemistry.
[70] T. Peretz,et al. Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases , 2009, PloS one.
[71] N. Rocamora,et al. Ezrin links syndecan-2 to the cytoskeleton. , 2000, Journal of cell science.
[72] H. P. Sørensen,et al. Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism* , 2008, Journal of Biological Chemistry.
[73] J. Guan,et al. Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. , 2009, Diabetes research and clinical practice.
[74] Bryan A. Millis,et al. Secreted Neutral Metalloproteases of Bacillus anthracis as Candidate Pathogenic Factors* , 2006, Journal of Biological Chemistry.
[75] M. Klagsbrun,et al. Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin. , 2004, The Journal of biological chemistry.
[76] F. Zhan,et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density. , 2003, Cancer research.
[77] P. Slocombe,et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. , 1998, FEBS letters.
[78] D. Edwards,et al. The ADAM metalloproteinases , 2008, Molecular Aspects of Medicine.
[79] M. Laato,et al. Induced expression of syndecan in healing wounds , 1991, The Journal of cell biology.
[80] Joseph L Goldstein,et al. Regulated Intramembrane Proteolysis A Control Mechanism Conserved from Bacteria to Humans , 2000, Cell.
[81] J. Couchman,et al. A Conserved NXIP Motif Is Required for Cell Adhesion Properties of the Syndecan-4 Ectodomain* , 2006, Journal of Biological Chemistry.
[82] M. Götte,et al. Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. , 2005, Biochemistry.
[83] J. Woessner,et al. Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7)* , 2000, The Journal of Biological Chemistry.
[84] J. Couchman. Syndecans: proteoglycan regulators of cell-surface microdomains? , 2003, Nature Reviews Molecular Cell Biology.
[85] J. Quigley,et al. Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.
[86] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[87] W. Parks,et al. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.
[88] R. Fässler,et al. The Cysteine-Rich Domain of Human Adam 12 Supports Cell Adhesion through Syndecans and Triggers Signaling Events That Lead to β1 Integrin–Dependent Cell Spreading , 2000, The Journal of cell biology.
[89] V. Trinkaus-Randall,et al. Localization of integrin and syndecan in vivo in a corneal epithelial abrasion and keratectomy. , 1991, Current eye research.
[90] A. Rapraeger,et al. Tyrosine Phosphorylation of Syndecan-1 and -4 Cytoplasmic Domains in Adherent B82 Fibroblasts* , 1998, The Journal of Biological Chemistry.
[91] M Kashiwagi,et al. TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* , 2001, The Journal of Biological Chemistry.
[92] Y. Yun,et al. Transmembrane Domain-induced Oligomerization Is Crucial for the Functions of Syndecan-2 and Syndecan-4* , 2005, Journal of Biological Chemistry.
[93] E. Chaikof,et al. Oxidized linoleic acid regulates expression and shedding of syndecan-4. , 2005, American journal of physiology. Cell physiology.
[94] Masato Kato,et al. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. , 1995, Molecular biology of the cell.
[95] K. Brew,et al. TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix* , 2000, The Journal of Biological Chemistry.
[96] M. Dhodapkar,et al. Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic Regions , 2001, Modern Pathology.
[97] Brian J. Ell,et al. Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor , 2009, The Journal of experimental medicine.
[98] Paul Martin,et al. Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.
[99] A. Bennett,et al. Streptococcus pneumoniae Sheds Syndecan-1 Ectodomains through ZmpC, a Metalloproteinase Virulence Factor* , 2007, Journal of Biological Chemistry.
[100] M. Simons,et al. Regulation of Syndecan-4 Phosphorylation in Vivo * , 1998, The Journal of Biological Chemistry.
[101] X. Leleu,et al. Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor , 2004, Leukemia.
[102] Jeffrey D. Esko,et al. Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.
[103] Séverine Brulé,et al. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. , 2006, Glycobiology.
[104] A. Woods,et al. Syndecan-2 Is Expressed in the Microvasculature of Gliomas and Regulates Angiogenic Processes in Microvascular Endothelial Cells* , 2006, Journal of Biological Chemistry.
[105] J. Couchman,et al. Syndecans as receptors and organizers of the extracellular matrix , 2009, Cell and Tissue Research.
[106] C. Vita,et al. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44. , 2004, Glycobiology.
[107] C. Yeaman,et al. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. , 1996, The Biochemical journal.
[108] A. Woods,et al. Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain. , 1997, Archives of biochemistry and biophysics.
[109] Gillian Murphy,et al. Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase , 2000, The Journal of cell biology.
[110] J. Enghild,et al. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. , 2009, Matrix biology : journal of the International Society for Matrix Biology.
[111] V. Hascall,et al. Cell surface heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.
[112] M. Stepp,et al. ORIGINAL RESEARCH – BASIC SCIENCE: Primary dermal fibroblasts derived from sdc‐1 deficient mice migrate faster and have altered αv integrin function , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[113] S. Munteanu,et al. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[114] B. Barlogie,et al. Elevated levels of shed syndecan‐1 correlate with tumour mass and decreased matrix metalloproteinase‐9 activity in the serum of patients with multiple myeloma , 1997, British journal of haematology.
[115] L. Devy,et al. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. , 2004, The American journal of pathology.
[116] Bernd Giese,et al. Latent MMP-9 is bound to TIMP-1 before secretion , 2007, Biological chemistry.
[117] M. Klagsbrun,et al. Activation of Syndecan-1 Ectodomain Shedding by Staphylococcus aureus α-Toxin and β-Toxin* , 2004, Journal of Biological Chemistry.
[118] M. Humphries,et al. Synergistic control of cell adhesion by integrins and syndecans , 2007, Nature Reviews Molecular Cell Biology.
[119] P. Slocombe,et al. The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.
[120] S. Curran,et al. Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Phenotype Identifies Poor Prognosis Colorectal Cancers , 2004, Clinical Cancer Research.
[121] S. Selleck,et al. The Heparan Sulfate Proteoglycans Dally-like and Syndecan Have Distinct Functions in Axon Guidance and Visual-System Assembly in Drosophila , 2005, Current Biology.
[122] R. Khokha,et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.
[123] R. Sanderson,et al. Identification of an Invasion Regulatory Domain within the Core Protein of Syndecan-1* , 2005, Journal of Biological Chemistry.
[124] H. Larjava,et al. Expression of proteoglycans and hyaluronan during wound healing. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[125] A. Rapraeger,et al. Syndecans in tumor cell adhesion and signaling , 2004, Reproductive biology and endocrinology : RB&E.
[126] M. Rouabhia,et al. Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan‐1 expressed by gingival epithelial cells , 2005, Journal of cellular physiology.